Partner With Us NRI

Company details

6M Return -13.55%
1Y Return -28.28%
Mkt Cap.(Cr) 7,187.45
Volume 287
Div Yield 2.97%
OI Chg %
Volume 287

Open Free Demat Account Online with ICICIDIRECT


  • swot

  • technicals

  • deals

  • shareholding


Delivery and volume

Our Research View

Trading recommendation

Data not found

Investment recommendation

Ex-VMS portfolio propels growth; consistency to be seen

Call Date

06 May 2022

Entry Price


Target Price



12-18 Month


  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio


Operating Profit(Cr.)

Profit after Tax(Cr.)


Reserves and Surplus



Operating Profit

Profit after tax





Equity Capital: 703.71 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 22,733.13 -37,122.02
LAST 3M 74,205.53 -50,398.80
LAST 6M 139,333.16 -187,387.57
LAST 12M 206,053.08 -175,138.09
  • Announcement
  • Corporate action
  • No Data Found

Date Action Type Ratio
May 12, 2022 Dividend 410
Nov 02, 2021 Dividend 400
Nov 02, 2021 Dividend 900


  • About Company
  • Company Info
  • Listing Info
  • Proctor & Gamble Health Ltd is in the Pharmaceuticals sector is having a market capitalization worth Rs. 8,936.24 crores, it was incorporated in the year 1967. It has reported consolidated sales of Rs. 22,239.0 crores in March’2021. The company is listed on the Bombay Stock Exchange (BSE) with the code 500126 and is listed on the National Stock Exchange (NSE) with the code PGHL.

    Proctor & Gamble Health Ltd, originally incorporated under the name Merck Ltd, is involved in manufacturing and supplying pharmaceuticals and chemicals. The company's pharmaceuticals division is involved in producing prescription drugs, biotechnology products, and consumer health products. At the same time, the chemicals division is involved in supplying pharmaceutical chemicals, formulated chemical products, industrial chemicals, and other chemical products. Proctor & Gamble completed the acquisition of Merck Ltd in December’2018. Its manufacturing facility is established in Goa. Proctor & Gamble Health Ltd, in pursuing the Corporate Social Responsibility requirements, have introduced various health and education schemes aimed at underprivileged children and women of the country. The promoters of the company own 51.82% of the stake in the company, Foreign Institutional Investors (FII) own 6.45%, Domestic Institutional Investors (DII) own 11.81% stake in the company, and others (such as public & retail investors) hold the balance of 29.92%.

    In March 2021, quarterly net revenue was Rs. 219.15 crores, which has decreased marginally by approximately 3.93 % from Rs. 228.11 crores for the January-March 2020 quarter. The quarterly net profit in March 2021 was Rs. 15.17 crores, which has reduced and decreased by nearly 67.35% from a net profit of Rs. 46.46 crores in March 2020. In March 2021, the reported operating profit was at Rs. 138.29 crores, which is also decreased by 19.76% as compared to an operating profit of Rs. 172.34 crores for the quarter ending in March 2020. From an EPS of Rs. 28 in March 2020, the EPS of Proctor & Gamble Health Ltd has reduced and reached Rs. 9.5 per share in March 2021. PGHL's stock closed at Rs. 5,383.60 on 20th August’2021 (NSE) and has given a negative return of 23.78% in the last six months and an annual return of 14.67% in the previous year.

Read More

Registered Address

Godrej One 8th Floor, Projshanagar Vikhroli (East), Mumbai, Maharashtra, 400079

Tel : 91-22-62109000
Email : investorgrievance.im:pg.com
Website : http://www.pghealthindia.com


Sharepro Services India P Ltd

AGM Date (Month) : Nov
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 500126
Book Closure Date (Month) :
BSE Group : A
ISIN : INE199A01012

ICICIdirect Procter & Gamble Health Ltd FAQ

You can buy Procter & Gamble Health Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Procter & Gamble Health Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 24, 2022 04:01 PM the closing price of Procter & Gamble Health Ltd was ₹ 4,330.05.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 24, 2022 04:01 PM, the market cap of Procter & Gamble Health Ltd stood at ₹ 7,187.45.
The latest PE ratio of Procter & Gamble Health Ltd as of May 24, 2022 04:01 PM is 39.16
The latest PB ratio of Procter & Gamble Health Ltd as of May 24, 2022 04:01 PM is 0.08
The 52-week high of Procter & Gamble Health Ltd is ₹ 6,099.00 while the 52-week low is ₹ 3,998.85 .
According to analyst recommendations, Procter & Gamble Health Ltd has a “Buy” rating for the long term.

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote